COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

News Releases

News Releases

Date
Title
Document
January 15, 2021
BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting
PDF Version
November 20, 2020
BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
PDF Version
November 11, 2020
BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
PDF Version
November 5, 2020
BioDelivery Sciences Reports Strong Q3 2020 Results
PDF Version
November 4, 2020
BioDelivery Sciences Announces $25 Million Share Repurchase Program
PDF Version
November 4, 2020
BioDelivery Sciences Announces Appointment of Jeff Bailey as Permanent CEO
PDF Version
October 23, 2020
BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020
PDF Version
September 11, 2020
BioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management
PDF Version
September 3, 2020
BioDelivery Sciences to Present at Two Upcoming Investor Conferences
PDF Version
August 5, 2020
BioDelivery Sciences Reports Strong Q2 2020 Results
PDF Version

Investor Presentation

More information is coming soon.


Upcoming Events

More events are coming soon.

Stay Connected

Stay up to date on the latest news

Get started now
December 21, 2020 /
Data provided by West LLC. Minimum 15 minutes delayed.